艾滋病毒感染被复合溶性CD4阻断在体外
R A Fisher1, J M Bertonis, W Meier
1Biogen Research Corporation, Cambridge, Massachusetts 02142.
Nature
|January 7, 1988
概括
重组可溶性CD4 (rsT4) 有效抑制人类免疫缺陷病毒1型 (HIV-1) 复制和细胞融合. 这种可溶性受体显示出作为HIV感染抗病毒疗法的潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
- 生物技术是生物技术.
背景情况:
- CD4 (T4) 是人类免疫缺陷病毒1型 (HIV-1) 的主要细胞受体.
- 艾滋病毒-1的识别是由其包裹糖蛋白 (gp120) 与CD4.4结合的介导.
- 获得性免疫缺陷综合征 (艾滋病) 是由HIV-1感染引起的.
研究的目的:
- 研究复合溶性CD4 (rsT4) 作为HIV-1的抑制剂的潜力.
- 评估rsT4阻止HIV-1复制和细胞融合的能力.
主要方法:
- 从转染的中国仓鼠卵巢细胞中净化复合溶性CD4 (rsT4).
- 在体外测试rst4对HIV-1复制的抑制作用.
- 评估rsT4防止病毒诱导的细胞融合 (syncytium形成) 的能力.
主要成果:
- 再组合可溶性CD4 (rsT4) 强烈抑制了HIV-1复制.
- rsT4有效地阻断了病毒诱导的细胞融合 (syncytium形成).
- 这些发现证实了rsT4的结合HIV的能力.
结论:
- 复合溶性CD4 (rsT4) 显示出针对HIV-1的显著抗病毒活性.
- rsT4代表了开发新型抗艾滋病毒疗法的有希望的候选人.
相关概念视频
Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...


